These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 881345)

  • 41. Combined reticuloendothelial stimulation and long-term, intermittent DTPA therapy in poisoning by polymeric plutonium. ANL-7409.
    Rosenthal MW; Smoler HM; Lindenbaum A
    ANL Rep; 1967; ():180. PubMed ID: 5308231
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effectiveness of pentacin (DTPA) in deposition of Ce144 in lung tissue].
    Borisov VP; Korolev GK
    Med Radiol (Mosk); 1967 Feb; 12(2):79-81. PubMed ID: 5616164
    [No Abstract]   [Full Text] [Related]  

  • 43. Progress in the beagle studies at Colorado State University.
    Watters RL; Lebel JL
    Health Phys; 1972 Jun; 22(6):811-4. PubMed ID: 5084015
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparison of Ca-DTPA and Zn-DTPA for chelating 241Am in beagles.
    Lloyd RD; Mays CW; McFarland SS; Taylor GN; Atherton DR
    Health Phys; 1976 Sep; 31(3):281-4. PubMed ID: 977350
    [No Abstract]   [Full Text] [Related]  

  • 45. [Behavior and biological effect of 239Pu on entry into a skin abrasion].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AN; Siniakov EG
    Med Radiol (Mosk); 1983 Feb; 28(2):46-51. PubMed ID: 6835046
    [No Abstract]   [Full Text] [Related]  

  • 46. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
    Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
    Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of Zn-DTPA in removing plutonium from the human body.
    Ohlenschläger L
    Health Phys; 1976 Feb; 30(2):249-50. PubMed ID: 1245431
    [No Abstract]   [Full Text] [Related]  

  • 48. The in vivo solubility of plutonium-239 dioxide in the rat lung.
    Smith H; Stradling GN; Loveless BW; Ham GJ
    Health Phys; 1977 Dec; 33(6):539-51. PubMed ID: 604297
    [No Abstract]   [Full Text] [Related]  

  • 49. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary lavage with saline and DTPA plus saline as a therapeutic measure for beagle dogs exposed to a 144Ce-labeled CsCl aerosol. LF-41.
    Pfleger RC; McClellan RO; Harvey JW; Sesline DH
    Fission Prod Inhal Proj; 1969 Nov; ():214-20. PubMed ID: 5310181
    [No Abstract]   [Full Text] [Related]  

  • 51. Removal of polymeric plutonium from dogs with DTPA and glucan.
    Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
    Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
    [No Abstract]   [Full Text] [Related]  

  • 52. Decorporation of Pu and Am from beagles with delayed daily injections of 3,4,3-LICAM(C) or Zn-DTPA.
    Mays CW; Lloyd RD; Jones CW; Bruenger FW; Taylor GN; Durbin PW; White D; Raymond KN
    Health Phys; 1986 Apr; 50(4):530-4. PubMed ID: 3754241
    [No Abstract]   [Full Text] [Related]  

  • 53. PREVENTION OF PLUTONIUM AND NEPTUNIUM DEPOSITION. HW-76000.
    SMITH VH
    HW SA US At Energy Comm; 1963 Jan; 86():143-8. PubMed ID: 24547059
    [No Abstract]   [Full Text] [Related]  

  • 54. Promotion by tetrameric catechoylamide ligands and CaNa3-DTPA of the dissociation in vitro of the Pu-transferrin complex formed after intravenous injection of Pu-tri-N-butylphosphate.
    Metivier H; Masse R; Durbin PW; Raymond KN
    Health Phys; 1985 Dec; 49(6):1302-5. PubMed ID: 3841100
    [No Abstract]   [Full Text] [Related]  

  • 55. The distribution and decorporation of 234Th in the rat as influenced by the mass of thorium administered.
    Peter-Witt E; Volf V
    Strahlentherapie Sonderb; 1985; 80():183-5. PubMed ID: 4095727
    [No Abstract]   [Full Text] [Related]  

  • 56. [Biological effects of the intramuscular administration of 239Pu as affected by chelate therapy].
    Siniakov EG; Nifatov AP; Bazhin AG; Liubchanskiĭ ER
    Med Radiol (Mosk); 1988 Mar; 33(3):60-3. PubMed ID: 3352497
    [No Abstract]   [Full Text] [Related]  

  • 57. Effectiveness of early DTPA treatments in two types of plutonium exposures in humans.
    Lagerquist CR; Hammond SE; Putzier EA; Piltingsrud CW
    Health Phys; 1965 Nov; 11(11):1177-80. PubMed ID: 5867870
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evaluation and correction of the vitamin C status in relation to the problem of the experimental modification of long-term radiation effects].
    Beliaev IK
    Radiobiologiia; 1991; 31(6):819-23. PubMed ID: 1767012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can mixed ligand therapy completely remove plutonium from the body?
    Volf V
    Health Phys; 1980 Aug; 39(2):364-6. PubMed ID: 7429860
    [No Abstract]   [Full Text] [Related]  

  • 60. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
    Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
    Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.